Patients with BRCA1-linked hereditary tumours have a favourable survival compared to sporadic tumours, possibly because of a good response to chemotherapy (Boyd et al, 2000; Chetrit et al, 2008). The gene discussed is BRCA1; the disease is neoplasm.